EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States

Kashish Goel iD, Raj Makkar, Amar Krishnaswamy iD, Samir R Kapadia iD, Susheel K Kodali, Ashish Shah, Colin M Barker iD, Ke Xu, Abhijeet Dhoble iD, Pradeep Yadav, Charanjit S Rihal iD, Amr E Abbas und 2 weitere

Circulation · 05.11.2024 · 150 (19) · 1493-1504

DOI: 10.1161/circulationaha.124.068847 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 05.11.2024. Verfasst von Kashish Goel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, TN (K.G., A.S., C.M.B.). Hauptthemen laut MEDLINE: Mitral Valve, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Registries. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous transcatheter valve therapy registry analyses of transcatheter mitral valve in valve (MViV) replacement of degenerated bioprosthesis reported early experience in the United States. Given recent increases in transseptal MViV volumes and introduction of the SAPIEN 3 Ultra valve, it is important to determine contemporary outcomes for patients undergoing transseptal SAPIEN 3/SAPIEN 3 Ultra MViV replacement. METHODS: The Society of Thoracic Surgeons (STS)/American College of Cardiology Transcatheter Valve Therapy Registry was used to extract data for all patients undergoing transseptal SAPIEN 3/SAPIEN 3 Ultra MViV from 2015 to September 2022. Primary efficacy outcome was 1-year all-cause mortality. Secondary end points included 30-day mortality, functional class, quality of life, and mitral valve performance. Primary safety outcomes were device success and in-hospital complications. RESULTS: A total of 4243 patients with a mean±SD STS score of 9.2±7.7 underwent transseptal MViV at 455 sites. The rate of Mitral Valve Academic Research Consortium technical (96.6%) success was high, and procedural complications were low. All-cause in-hospital, 30-day, and 1-year mortality rates were 3.2%, 4.3%, and 13.4%, respectively. Significant improvements in New York Heart Association class (New York Heart Association I/II, 18% to 87%) and quality of life (Kansas City Cardiomyopathy Questionnaire score, 38 to 78) were noted at 1 year ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral ValveHeart Valve ProsthesisHeart Valve Prosthesis ImplantationRegistriesHumansMaleFemaleUnited StatesAgedTreatment OutcomeAged, 80 and overCardiac CatheterizationQuality of LifeProsthesis DesignHospital MortalityMiddle Aged

Stichwörter der Autor:innen

MVIVintermediate riskmitral valve in valveoutcomestransseptal

Autor:innen und Institutionen

  • Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, TN (K.G., A.S., C.M.B.).
  • Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (R.M.).
  • Department of Cardiovascular Medicine, Cleveland Clinic, OH (A.K., S.R.K.).
  • Division of Cardiology, Columbia University Medical Center, New York, NY (S.K.K.).
  • Edwards Lifesciences, Irvine, CA (K.X.).
  • Division of Cardiology, Memorial Hermann Hospital, Houston, TX (A.D.).

ORCID-Profile: Kashish Goel, Amar Krishnaswamy, Samir R Kapadia, Colin M Barker, Abhijeet Dhoble, Charanjit S Rihal, Mayra Guerrero, Brian K Whisenant

Zitieren

APA

Goel, K., Makkar, R., Krishnaswamy, A., Kapadia, S. R., Kodali, S. K., Shah, A., Barker, C. M., Xu, K., Dhoble, A., Yadav, P., Rihal, C. S., Abbas, A. E., Guerrero, M., & Whisenant, B. K. (2024). Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States. Circulation, 150(19), 1493-1504. https://doi.org/10.1161/circulationaha.124.068847

Vancouver

Goel K, Makkar R, Krishnaswamy A, Kapadia SR, Kodali SK, Shah A, et al. Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States. Circulation. 2024;150(19):1493-1504. doi:10.1161/circulationaha.124.068847

BibTeX
@article{Goel2024,
  author = {Goel, Kashish and Makkar, Raj and Krishnaswamy, Amar and Kapadia, Samir R and Kodali, Susheel K and Shah, Ashish and Barker, Colin M and Xu, Ke and Dhoble, Abhijeet and Yadav, Pradeep and Rihal, Charanjit S and Abbas, Amr E and Guerrero, Mayra and Whisenant, Brian K},
  title = {Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {19},
  pages = {1493--1504},
  doi = {10.1161/circulationaha.124.068847}
}
Kostenlos starten →